Tag: RAMM Pharma Corp.

July 9, 2020

RAMM Pharma Announces Approval and Registration of Epifractán™ 5 Percent by Peru’s Ministry of Health and Enters Distribution Agreement to Supply Pharmacies in Peru

RAMM Pharma Corp. is pleased to announce that the Company’s Epifractán™ 5% formulation has been approved and registered by Peru’s...
November 8, 2019

RAMM Pharma Corp. Commences Trading on the CSE Under Ticker Symbol “RAMM”

RAMM Pharma (CSE:RAMM) begins trading on the Canadian Securities Exchange today under the ticker symbol “RAMM”.
October 30, 2019

RAMM Pharma Corp. Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.

RAMM Pharma Corp. is pleased to announce that on October 28, 2019 it completed its business combination with Medic Plast...
October 29, 2019

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.; Trading Anticipated to Commence November 8, 2019

RAMM Pharma Corp. (CSE:RAMM) is pleased to announce that on October 28, 2019 it completed its previously announced business combination...